Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 765

1.

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P.

Liver Transpl. 2000 Nov;6(6):741-8.

PMID:
11084061
[PubMed - indexed for MEDLINE]
Free Article
2.

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.

Dodson SF, de Vera ME, Bonham CA, Geller DA, Rakela J, Fung JJ.

Liver Transpl. 2000 Jul;6(4):434-9.

PMID:
10915164
[PubMed - indexed for MEDLINE]
Free Article
3.

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.

Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, Schmidt P, Pakrasi A, Artinian L, Murray NG, Imagawa DK, Holt C, Goldstein LI, Stribling R, Busuttil RW.

Hepatology. 1998 Aug;28(2):585-9.

PMID:
9696028
[PubMed - indexed for MEDLINE]
4.

Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.

Han SH, Martin P, Edelstein M, Hu R, Kunder G, Holt C, Saab S, Durazo F, Goldstein L, Farmer D, Ghobrial RM, Busuttil RW.

Liver Transpl. 2003 Feb;9(2):182-7.

PMID:
12548512
[PubMed - indexed for MEDLINE]
Free Article
5.

Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.

Karasu Z, Ozacar T, Akyildiz M, Demirbas T, Arikan C, Kobat A, Akarca U, Ersoz G, Gunsar F, Batur Y, Kilic M, Tokat Y.

Antivir Ther. 2004 Dec;9(6):921-7.

PMID:
15651751
[PubMed - indexed for MEDLINE]
6.

Evolving experience of hepatitis B virus prophylaxis in liver transplantation.

Honaker MR, Shokouh-Amiri MH, Vera SR, Alloway RR, Grewal HP, Hardinger KL, Kizilisik AT, Bagous T, Trofe J, Stratta RJ, Egidi MF, Gaber AO.

Transpl Infect Dis. 2002 Sep;4(3):137-43.

PMID:
12421458
[PubMed - indexed for MEDLINE]
7.

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.

Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR.

Liver Transpl Surg. 1999 Nov;5(6):491-6.

PMID:
10545536
[PubMed - indexed for MEDLINE]
8.

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

Angus PW, McCaughan GW, Gane EJ, Crawford DH, Harley H.

Liver Transpl. 2000 Jul;6(4):429-33.

PMID:
10915163
[PubMed - indexed for MEDLINE]
Free Article
9.

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation.

Buti M, Mas A, Prieto M, Casafont F, González A, Miras M, Herrero JI, Jardí R, Cruz de Castro E, García-Rey C.

J Hepatol. 2003 Jun;38(6):811-7.

PMID:
12763375
[PubMed - indexed for MEDLINE]
10.

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin.

Yoshida EM, Erb SR, Partovi N, Scudamore CH, Chung SW, Frighetto L, Eggen HJ, Steinbrecher UP.

Liver Transpl Surg. 1999 Nov;5(6):520-5.

PMID:
10545541
[PubMed - indexed for MEDLINE]
11.

Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin.

McCaughan GW, Spencer J, Koorey D, Bowden S, Bartholomeusz A, Littlejohn M, Verran D, Chui AK, Sheil AG, Jones RM, Locarnini SA, Angus PW.

Liver Transpl Surg. 1999 Nov;5(6):512-9.

PMID:
10545540
[PubMed - indexed for MEDLINE]
12.

Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.

Ołdakowska-Jedynak U, Paczek L, Foroncewicz B, Mucha K, Nyckowski P, Zieniewicz K, Ziarkiewicz-Wróblewska B, Ziółkowski J, Pilecki T, Patkowski W, Górnicka B, Paczkowska A, Krawczyk M.

Ann Transplant. 2007;12(3):28-32.

PMID:
18290567
[PubMed - indexed for MEDLINE]
13.

Hepatitis B: progress in the last 15 years.

Villamil FG.

Liver Transpl. 2002 Oct;8(10 Suppl 1):S59-66. Review.

PMID:
12362301
[PubMed - indexed for MEDLINE]
Free Article
14.

Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.

Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, McCaughan GW; Australasian Liver Transplant Study Group.

Gastroenterology. 2007 Mar;132(3):931-7. Epub 2007 Jan 5.

PMID:
17383422
[PubMed - indexed for MEDLINE]
15.

Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?

van Nunen AB, de Man RA, Heijtink RA, Vossen AC, Schalm SW.

J Viral Hepat. 2002 May;9(3):221-8.

PMID:
12010511
[PubMed - indexed for MEDLINE]
16.
17.

Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.

Seehofer D, Rayes N, Steinmüller T, Müller AR, Jonas S, Settmacher U, Neuhaus R, Berg T, Neuhaus P.

Z Gastroenterol. 2002 Sep;40(9):795-9.

PMID:
12215948
[PubMed - indexed for MEDLINE]
18.

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.

Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.

Liver Transpl. 2001 Jun;7(6):513-7.

PMID:
11443579
[PubMed - indexed for MEDLINE]
Free Article
19.

Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

Ferretti G, Merli M, Ginanni Corradini S, Callejon V, Tanzilli P, Masini A, Ferretti S, Iappelli M, Rossi M, Rivanera D, Lilli D, Mancini C, Attili A, Berloco P.

Transplant Proc. 2004 Apr;36(3):535-8.

PMID:
15110584
[PubMed - indexed for MEDLINE]
20.

Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.

Tchervenkov JI, Tector AJ, Barkun JS, Sherker A, Forbes CD, Elias N, Cantarovich M, Cleland P, Metrakos P, Meakins JL.

Ann Surg. 1997 Sep;226(3):356-65; discussion 365-8.

PMID:
9339942
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk